MedTrace Logo

Improving Prostate Lesion Classification and Development of a PI-RADS 3 Classifier

NCT06116344 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 173

Last updated 2023-11-03

No results posted yet for this study

Summary

The investigators propose an AI methodology combining machine learning, histological results and expert image interpretation for the development of a PI-RADS 3 classifier.

Conditions

Sponsors & Collaborators

  • Paracelsus Medical University

    lead OTHER

Principal Investigators

  • Michael M. Lell, Prof. Dr. med. · Department of Radiology and Nuclear Medicine, Klinikum Nuernberg, Paracelsus Medical University, Germany

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2020-12-31
Completion
2023-08-24

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06116344 on ClinicalTrials.gov